Medicenna Therapeutics Corp. (MDNAF): 6-K filed Apr 30, 2024

Form type

6-K

Filing date

Apr 30, 2024

Accession number

0001104659-24-054880

Filer

Medicenna Therapeutics Corp. (CIK 1807983)